Advantech Capital is a private equity fund focused on innovation-driven growth capital in China. The firm makes minority investments through growth equity and later-stage venture capital across TMT, e-services, and healthcare sectors.
Their most common stage is series-b (56% of deals). Average disclosed round size is $92.5M (across 8 rounds with reported amounts).
Portfolio
9
Fund Size
$560M
Top Stage
Series B
Last 12 Mo
0
Team
AH
Allen Hu
Venture Partner
BQ
Benjamin Qiu
Partner, Co-Head of Healthcare Investment
W(
Wenting (Julia) chen
Venture Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAblaze Pharmaceuticals | Series A | $75M | Nov 2021 |
 Xiaozhu | Unknown | $300M | Oct 2018 |
 Harbour BioMed | Series B | $75M | Aug 2018 |
 Petuum, Inc. | Series B | $93M | Oct 2017 |
 Mojo | Series B | $10M | — |
 Sinovac Biotech | Unknown | $86.7M | — |
| HHarbour Antibodies | Series B | — | — |
| SSpot Biosystems | Unknown | $40M | — |
| 克克睿基因 | Series B | $60M | — |
Top Co-Investors
Vivo Capital2 shared
GIC Private Limited2 shared
Legend Capital2 shared
SoftBank Vision Fund1 shared
venBio1 shared
Pivotal Life Sciences1 shared
Samsara BioCapital1 shared
imec.xpand1 shared
New Enterprise Associates1 shared
Dolby Family Ventures1 shared
Vanedge Capital1 shared
Y Combinator1 shared
Gradient Ventures1 shared
Ohio Innovation Fund1 shared
Fusion Fund1 shared
Khosla Ventures1 shared
Hyperlink Ventures1 shared
Atlas Venture1 shared
Yunfeng Capital1 shared
Last updated: 9 September 2026